In a prior study of DYRK2 in CRC, Laham AJ et al. used publicly available data and web-based tools to investigate the status of DYRK expression in CRC by comparing these levels in normal and tumor tissue samples and across multiple stages, molecular subtypes, and histological subtypes of CRC. The gene discussed is DYRK1A; the disease is neoplasm.